qPCR Market is estimated to increase at a growth rate of 6.5% CAGR over the forecast period from 2024 to 2030.
The global qPCR Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Reagents & Consumables, Instruments, Software & Services), By Application (Clinical, Research, Forensics), By End-User (Hospitals &Diagnostic Centers, Research Laboratories & Academic Institutes, Pharmaceutical & Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories).
An Introduction to qPCR Market in 2024
Quantitative Polymerase Chain Reaction (qPCR) is a molecular biology technique used to amplify and quantify DNA or RNA samples. The qPCR Market encompasses a range of instruments, reagents, and software solutions designed for precise and high-throughput nucleic acid analysis. Key applications of qPCR include gene expression analysis, pathogen detection, genetic testing, and drug development research. Market trends include a growing demand for rapid and accurate diagnostic tools, advancements in qPCR technology such as digital PCR (dPCR), and increasing automation for streamlined workflow efficiency. Key players in the market are focusing on developing user-friendly platforms, multiplexing capabilities, and robust data analysis tools to meet the diverse needs of researchers and clinical laboratories.
qPCR Market Competitive Landscape
The global qPCR Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, qPCR Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the qPCR Industry include- ABL SA Group, Agilent Technologies Inc, Analytik Jena AG, Becton, Dickinson and Company, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Fluidigm Corp, Lumex Instruments, Primerdesign Ltd, Qiagen NV, Takara Bio Inc, Thermo Fisher Scientific Inc, TOYOBO Inc.
qPCR Market Trend: Shift towards Digital PCR (dPCR) Technology
In the realm of quantitative polymerase chain reaction (qPCR), a significant trend is the increasing adoption of digital PCR (dPCR) technology. While qPCR has long been the gold standard for nucleic acid quantification, dPCR offers advantages such as absolute quantification, improved sensitivity, and enhanced precision by partitioning samples into thousands of individual reaction chambers. This trend towards dPCR reflects the growing demand for more accurate and reliable nucleic acid quantification methods, particularly in applications such as rare mutation detection, copy number variation analysis, and absolute quantification of nucleic acids, driving the adoption of dPCR platforms in molecular diagnostics and research laboratories worldwide.
qPCR Market Driver: Growing Demand for Molecular Diagnostics
The growing demand for molecular diagnostics serves as a significant market driver for qPCR technology. Molecular diagnostics play a critical role in disease detection, monitoring, and personalized treatment decisions across various medical fields, including infectious diseases, oncology, genetic disorders, and reproductive health. qPCR technology enables rapid and sensitive detection and quantification of nucleic acids, making it indispensable for applications such as pathogen detection, genotyping, gene expression analysis, and viral load monitoring. As the global burden of infectious diseases, cancer, and genetic disorders continues to rise, there's a growing need for accurate and reliable molecular diagnostic assays, driving the demand for qPCR platforms and reagents in clinical and research settings.
qPCR Market Opportunity: Development of Multiplex qPCR Assays
A promising opportunity in the qPCR market lies in the development of multiplex qPCR assays that allow for simultaneous detection and quantification of multiple targets in a single reaction. Multiplex qPCR assays offer advantages such as reduced sample consumption, increased throughput, and cost savings by combining multiple assays into a single reaction. By targeting multiple genes, pathogens, or mutations in a single assay, multiplex qPCR enables comprehensive analysis of complex biological samples, such as clinical specimens and environmental samples, with improved efficiency and accuracy. Additionally, multiplex qPCR assays have applications in high-throughput screening, biomarker discovery, and gene expression profiling, offering new opportunities for innovation and market expansion in the field of molecular diagnostics. Investing in the development and commercialization of multiplex qPCR assays presents a strategic opportunity for diagnostic companies to address unmet clinical needs, enhance laboratory efficiency, and improve patient care in diverse diagnostic settings.
qPCR Market Share Analysis: Software & Services is the fastest growing market segment over the forecast period to 2030
Within the qPCR (quantitative polymerase chain reaction) market, the segment experiencing the fastest growth is Software & Services. This growth can be attributed to the increasing demand for advanced software solutions and specialized services that enhance the efficiency, accuracy, and automation of qPCR processes. As qPCR technology continues to evolve and become more sophisticated, there is a rising need for intuitive software platforms that can handle complex data analysis, interpretation, and visualization. Additionally, service providers offer valuable support in assay design, protocol optimization, and data interpretation, catering to the diverse needs of clinical, research, and forensic applications. Moreover, with the expansion of qPCR usage across various end-user sectors, including hospitals, research laboratories, pharmaceutical companies, and forensic laboratories, the demand for software and services that streamline workflow and ensure regulatory compliance is expected to surge further, driving the rapid growth of this segment in the qPCR market.
qPCR Market Segmentation
By Product
Reagents & Consumables
Instruments
Software & Services
By Application
Clinical
Research
Forensics
By End-User
Hospitals &Diagnostic Centers
Research Laboratories & Academic Institutes
Pharmaceutical & Biotechnology Companies
Clinical Research Organizations
Forensic Laboratories
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
qPCR Companies
ABL SA Group
Agilent Technologies Inc
Analytik Jena AG
Becton, Dickinson and Company
Bio-Rad Laboratories Inc
F. Hoffmann-La Roche Ltd
Fluidigm Corp
Lumex Instruments
Primerdesign Ltd
Qiagen NV
Takara Bio Inc
Thermo Fisher Scientific Inc
TOYOBO Inc
* List not Exhaustive
Reasons to Buy the qPCR Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the qPCR Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the qPCR Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 qPCR Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global qPCR Market Size Outlook, $ Million, 2021 to 2030
3.2 qPCR Market Outlook by Type, $ Million, 2021 to 2030
3.3 qPCR Market Outlook by Product, $ Million, 2021 to 2030
3.4 qPCR Market Outlook by Application, $ Million, 2021 to 2030
3.5 qPCR Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of qPCR Industry
4.2 Key Market Trends in qPCR Industry
4.3 Potential Opportunities in qPCR Industry
4.4 Key Challenges in qPCR Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global qPCR Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global qPCR Market Outlook by Segments
7.1 qPCR Market Outlook by Segments, $ Million, 2021- 2030
By Product
Reagents & Consumables
Instruments
Software & Services
By Application
Clinical
Research
Forensics
By End-User
Hospitals &Diagnostic Centers
Research Laboratories & Academic Institutes
Pharmaceutical & Biotechnology Companies
Clinical Research Organizations
Forensic Laboratories
8 North America qPCR Market Analysis and Outlook To 2030
8.1 Introduction to North America qPCR Markets in 2024
8.2 North America qPCR Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America qPCR Market size Outlook by Segments, 2021-2030
By Product
Reagents & Consumables
Instruments
Software & Services
By Application
Clinical
Research
Forensics
By End-User
Hospitals &Diagnostic Centers
Research Laboratories & Academic Institutes
Pharmaceutical & Biotechnology Companies
Clinical Research Organizations
Forensic Laboratories
9 Europe qPCR Market Analysis and Outlook To 2030
9.1 Introduction to Europe qPCR Markets in 2024
9.2 Europe qPCR Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe qPCR Market Size Outlook by Segments, 2021-2030
By Product
Reagents & Consumables
Instruments
Software & Services
By Application
Clinical
Research
Forensics
By End-User
Hospitals &Diagnostic Centers
Research Laboratories & Academic Institutes
Pharmaceutical & Biotechnology Companies
Clinical Research Organizations
Forensic Laboratories
10 Asia Pacific qPCR Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific qPCR Markets in 2024
10.2 Asia Pacific qPCR Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific qPCR Market size Outlook by Segments, 2021-2030
By Product
Reagents & Consumables
Instruments
Software & Services
By Application
Clinical
Research
Forensics
By End-User
Hospitals &Diagnostic Centers
Research Laboratories & Academic Institutes
Pharmaceutical & Biotechnology Companies
Clinical Research Organizations
Forensic Laboratories
11 South America qPCR Market Analysis and Outlook To 2030
11.1 Introduction to South America qPCR Markets in 2024
11.2 South America qPCR Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America qPCR Market size Outlook by Segments, 2021-2030
By Product
Reagents & Consumables
Instruments
Software & Services
By Application
Clinical
Research
Forensics
By End-User
Hospitals &Diagnostic Centers
Research Laboratories & Academic Institutes
Pharmaceutical & Biotechnology Companies
Clinical Research Organizations
Forensic Laboratories
12 Middle East and Africa qPCR Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa qPCR Markets in 2024
12.2 Middle East and Africa qPCR Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa qPCR Market size Outlook by Segments, 2021-2030
By Product
Reagents & Consumables
Instruments
Software & Services
By Application
Clinical
Research
Forensics
By End-User
Hospitals &Diagnostic Centers
Research Laboratories & Academic Institutes
Pharmaceutical & Biotechnology Companies
Clinical Research Organizations
Forensic Laboratories
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
ABL SA Group
Agilent Technologies Inc
Analytik Jena AG
Becton, Dickinson and Company
Bio-Rad Laboratories Inc
F. Hoffmann-La Roche Ltd
Fluidigm Corp
Lumex Instruments
Primerdesign Ltd
Qiagen NV
Takara Bio Inc
Thermo Fisher Scientific Inc
TOYOBO Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
